E2 and the co-activator p300 can cooperate in activation of the human papillomavirus type 16 early promoter

Virology

Volumn 377, Issue 1, 2008, Pages 151-159

  Krüppel, Ulla ^a   Müller Schiffmann, Andreas ^b   Baldus, Stephan E ^b   Smola Hess, Sigrun ^a   Steger, Gertrud ^a  

^a UNIVERSITY OF COLOGNE   (Germany)

^b HEINRICH HEINE UNIVERSITY   (Germany)

Author keywords

C EBP ; Coactivator p300; HPV16E2; Regulation of HPV16 early promoter

Indexed keywords

CCAAT ENHANCER BINDING PROTEIN ALPHA; GLYCOPROTEIN E2; PROTEIN P300;

ARTICLE; BINDING SITE; CELL DIFFERENTIATION; CONTROLLED STUDY; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN PAPILLOMAVIRUS TYPE 16; IMMUNOHISTOCHEMISTRY; KERATINOCYTE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; VIRUS ACTIVATION; VIRUS GENE; VIRUS TRANSCRIPTION;

BINDING SITES; CCAAT-ENHANCER-BINDING PROTEIN-ALPHA; DNA-BINDING PROTEINS; E1A-ASSOCIATED P300 PROTEIN; FEMALE; GENE EXPRESSION REGULATION, VIRAL; GENES, VIRAL; HUMAN PAPILLOMAVIRUS 16; HUMANS; ONCOGENE PROTEINS, VIRAL; PAPILLOMAVIRUS INFECTIONS; PROMOTER REGIONS (GENETICS); PROTEIN BINDING; UTERINE CERVICAL NEOPLASMS;

HUMAN PAPILLOMAVIRUS; HUMAN PAPILLOMAVIRUS TYPE 16; PAPILLOMAVIRIDAE;

EID: 44949246216     PISSN: 00426822     EISSN: 10960341     Source Type: Journal    
DOI: 10.1016/j.virol.2008.04.006     Document Type: Article

References (49)

1. Ai W., Toussaint E., and Roman A. CCAAT displacement protein binds to and negatively regulates human papillomavirus type 6 E6, E7, and E1 promoters. J. Virol. 73 (1999) 4220-4229
2. Baker C., and Calef C. Maps of papillomavirus m-RNA transcripts. In: Myers G., Baker C., Munger K., S.F., McBride A.A., and Bernrad H.-U. (Eds). Human Papillomaviruses 1997 (1996), Los Alamos National Laboratory, Los Alamos
3. Bechtold V., Beard P., and Raj K. Human papillimavirus type 16 E2 protein has no effect on transcription from episomal viral DNA. J. Virol. 77 (2003) 2021-2028
4. Bernard H.-U. Regulation of the transcription of genital human papillomaviruses by CDP, nucleosomes and nuclear matrix attachment regions. Papillomavirus Rep. 11 (2000) 73-80
5. Bouvard V., Storey A., Pim D., and Banks L. Characterization of the human papillomavirus E2 protein: evidence of trans-activation and trans-repression in cervical keratinocytes. EMBO J. 13 (1994) 5451-5459
6. Bull J.J., Muller-Rover S., Chronnell C.M., Paus R., Philpott M.P., and McKay I.A. Contrasting expression patterns of CCAAT/enhancer-binding protein transcription factors in the hair follicle and at different stages of the hair growth cycle. J. Invest. Dermatol. 118 1 (2002) 17-24
7. Carson A., and Khan S.A. Characterization of transcription factor binding to human papillomavirus type 16 DNA during cellular differentiation. J. Virol. 80 (2006) 4356-4362
8. Demeret C., Desaintes C., Yaniv M., and Thierry F. Different mechanisms contribute to the E2-mediated transcriptional repression of human papillomavirus type 18 viral oncogenes. J. Virol. 71 (1997) 9343-9349
9. Desaintes C., Demeret C., Goyat S., Yaniv M., and Thierry F. Expression of papillomavirus E2 protein in HeLa cells leads to apoptosis. EMBO J. 16 (1997) 504-514
10. Dong X.-P., Stubenrauch F., Beyer-Finkler E., and Pfister H. Prevalence of deletions of YY1-binding sites in episomal HPV 16 DNA from cervical cancers. Internatl. J. Cancer 58 (1994) 803-808
11. Doorbar J. Molecular biology of human papillomavirus infection and cervical cancer. Clin. Sci. 110 (2006) 525-541
12. Dowhanick J.J., McBride A.A., and Howley P.M. Suppression of cellular proliferation by the papillomavirus E2 protein. J. Virol. 69 (1995) 7791-7799
13. Eckner R., Ewen M.E., Newsome D., Gerdes M., DeCaprio J.A., Lawrence J.B., and Livingston D.M. Molecular cloning and functional analysis of the adenovirus E1A-associated 300-kD protein (p300) reveals a protein with properties of a transcriptional adaptor. Genes Dev. 8 (1994) 869-884
14. Glahder J.A., Hansen C.N., Vinther J., Madsen B.S., and Norrild B. A promoter within the E6 ORF of human papillomavirus type 16 contributes to the expression of the E7 oncoprotein from a monocistronic mRNA. J. Gen. Virol. 84 (2003) 3429-3441
15. Goodwin E.C., and DiMaio D. Repression of human papillomavirus oncogenes in HeLa cervical carcinoma cells causes an orderly reactivation of dormant tumor suppressor pathways. Proc. Natl. Acad. Sci. U. S. A. 97 (2000) 12513-12518
16. Grassmann K., Rapp B., Maschek H., Petry K.U., and Iftner T. Identification of a differentiation-inducible promoter in the E7 open reading frame of human papillomavirus type 16 (HPV16) in raft cultures of a new cell line containing high copy numbers of episomal HPV16-DNA. J. Virol. 70 (1996) 2339-2349
17. Hadaschik D., Hinterkeuser K., Oldak M., Pfister H., and Smola-Hess S. The papillomavirus E2 protein binds to and synergizes with C/EBP factors involved in keratinocyte differentiation. J. Virol. 77 (2003) 5253-5265
18. Kalantari M., Lee D., Calleja-Macias I.E., Lambert P.F., and Bernard H.U. Effects of cellular differentiation, chromosomal integration and 5-aza-2′-deoxycytidine treatment on human papillomavirus-16 DNA methylation in cultured cell lines. Virology 374 (2008) 292-303
19. Kalkhoven E. CBP and p300: HATs for different occasions. Biochem. Pharmacol. 68 (2004) 1145-1455
20. Kim K., Garner-Hamrick P.A., Fisher C., Lee D., and Lambert P.F. Methylation patterns of papillomavirus DNA, its influence on E2 function, and implications in viral infection. J. Virol. 77 (2003) 12450-12459
21. Kukimoto I., and Kanda T. Displacement of YY1 by differentiation-specific transcription factors hSkn-1a activates the P670 promoter of human papillomavirus type 16. J. Virol. 75 (2001) 9302-9311
22. Kukimoto I., Takeuchi T., and Kanda T. CCAAT/enhancer binding protein beta binds to and activates the P670 promoter of human papillomavirus type 16. Virology 346 (2006) 98-107
23. Kyo S., Inoue M., Nishio Y., Nakanishi K., Akira S., Inoue H., Yotsudo M., Tanizawa O., and Hakura A. NF-IL6 represses early gene expression of human papillomavirus type 16 through binding to the noncoding region. J. Virol. 67 (1993) 1058-1066
24. Lee D., Lee B., Kim J., Kim D.W., and Choe J. cAMP response element-binding protein-binding protein binds to human papillomavirus E2 protein and activates E2-dependent transcription. J. Biol. Chem. 275 (2000) 7045-7051
25. Longworth M.S., and Laimins L.A. Pathogenesis of human papillomaviruses in differentiating epithelia. Microbiol. Mol. Biol. Rev. 68 (2004) 362-372
26. Maitland N.J., Conway S., Wilkinson N.S., Ramsdale J., Morris J.R., Sanders C.M., Burns J.E., Stern P.L., and Wells M. Expression patterns of the human papillomavirus type 16 transcription factor E2 in low- and high-grade cervical intraepithelial neoplasia. J. Pathol. 186 (1998) 275-280
27. Marcello A., Masimi P., Banks L., and Giacca M. Adeno-associated virus type 2 rep protein inhibits human papillomavirus type 16 E2 recruitment of the transcriptional coactivator p300. J. Virol. 74 (2000) 9090-9098
28. Maytin E.V., and Habener J.F. Transcription factors C/EBP alpha, C/EBP beta, and CHOP (Gadd153) expressed during the differentiation program of keratinocytes in vitro and in vivo. J. Invest. Dermatol. 110 (1998) 238-246
29. McFie P.J., Wang G.L., Timchenko N.A., Wilson H.L., Hu X., and Roesler W.J. Identification of a co-repressor that inhibits the transcriptional and growth-arrest activities of CCAAT/enhancer-binding protein alpha. J. Biol. Chem. 281 (2006) 18069-18080
30. Mink S., Haenig B., and Klempnauer K.-H. Interaction and functional collaboration of p300 and C/EBPβ. Mol. Cell. Biol. 17 (1997) 6609-6617
31. Müller A., Ritzkowsky A., and Steger G. Cooperative activation of human papillomavirus type 8 gene expression by the E2 protein and the cellular coactivator p300. J. Virol. 76 (2002) 11042-11053
32. Müller-Schiffmann A., Beckmann J., and Steger G. The E6 protein of the cutaneous human papillomavirus type 8 can stimulate the viral early and late promoters by distinct mechanisms. J. Virol. 80 (2006) 8718-8728
33. Munoz N. Human papillomavirus and cancer: the epidemiological evidence. J. Clin. Virol. 19 (2000) 1-5
34. Nepveu A. Role of the multifunctional CDP/Cut/Cux homeodomain transcription factor in regulating differentiation, cell growth and development. Gene 270 (2001) 1-15
35. Nishimura A., Ono T., Ishimoto A., Dowhanick J.J., Frizell M.A., Howley P.M., and Sakai H. Mechanism of human papillomavirus E2-mediated repression of viral oncogene expression and cervical cancer cell growth inhibition. J. Virol. 74 (2000) 3752-3760
36. Peng Y.-C., Breiding D.E., Sverdrup F., Richard J., and Androphy E.J. AMF-1/Gps2 binds p300 and enhances its interaction with papillomavirus E2 proteins. J. Virol. 74 (2000) 5872-5879
37. Purdie K.J., Sexton C.J., Proby C.M., Glover M.T., Williams A.T., Stables J.N., and Leigh I.M. Malignant transformation of cutaneous lesions in renal allograft patients: a role for human papillomavirus. Cancer Res. 53 (1993) 5328-5333
38. Rosenstierne M.W., Vinther J., Hansen C.N., Prydsoe M., and Norrild B. Identification and characterization of a cluster of transcription start sites located in the E6 ORF of human papillomavirus type 16. J. Gen. Virol. 84 (2003) 2909-2920
39. Schwartz C., Beck K., Mink S., Schmolke M., Budde B., Wenning D., and Klempnauer K.-H. Recruitment of p300 by C/EBPβ triggers phosphorylation of p300 and modulates coactivator activity. EMBO J. 22 (2003) 882-892
40. Schwarz E., Freese U.K., Gissmann L., Mayer W., Roggenbuch A., Stremlau A., and zur Hausen H. Structure and transcription of human papillomavirus sequences in cervical carcinoma cells. Nature 314 (1985) 111-114
41. Smith C., Zhu K., Merritt A., Picton R., Youngs D., Garrod D., and Chidgey M. Regulation of desmocollin gene expression in the epidermis: CCAAT/enhancer-binding proteins modulate early and late events in keratinocyte differentiation. Biochem. J. 380 (2004) 757-765
42. Soeda E., Ferran M.C., Baker C.C., and McBride A.A. Repression of HPV16 early region transcription by the E2 protein. Virology 351 (2006) 29-41
43. Steger G., and Corbach S. Dose-dependent regulation of the early promoter of human papillomavirus type 18 by the viral E2 protein. J. Virol. 71 (1997) 50-58
44. Stevenson M., Hudson L.C., Burns J.E., Stewart R.L., Wells M., and Maitland N.J. Inverse relationship between the expression of the human papillomavirus type 16 transcription factor E2 and virus DNA copy number during the progression of cervical intraepithelial neoplasia. J. Gen. Virol. 81 (2000) 1825-1832
45. Stünkel W., Huang Z., Tan S.-H., O'Connor M.J., and Bernard H.-U. Nuclear matrix attachment regions of human papillomavirus type 16 repress or activate the E6 promoter, depending on the physical state of the viral DNA. J. Virol. 74 (2000) 2489-2501
46. Tan S.H., Gloss B., and Bernard H.-U. During negative regulation of the human papillomavirus-16 E6 promoter, the viral E2 protein can displace Sp1 from a proximal promoter element. Nucleic Acids Res. 20 (1992) 251-256
47. Verres G., Szarka K., Dong X.-P., Gergerly L., and Pfister H. Functional significance of sequence variations in the E2 gene and the long control region of human papillomavirus type 16. J. Gen. Virol. 80 (1999) 1035-1043
48. Weissenborn S.J., Funke A.M., Hellmich M., Mallmann P., Fuchs P.G., Pfister H.J., and Wieland U. Oncogenic human papillomavirus DNA loads in human immunodeficiency virus-positive women with high-grade cervical lesions are strongly elevated. J. Clin. Microbiol. 41 (2003) 2763-2767
49. Wooldridge T.R., and Laimins L.A. Regulation of human papillomavirus type 31 gene expression during the differentiation-dependent life cycle through histone modifications and transcription factor binding. Virology 374 (2008) 371-380